Related Experiment Videos
Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery
Michael E Halkos1, John D Puskas, Omar M Lattouf
1Clinical Research Unit, Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Insights
Adequate diabetic control, measured by hemoglobin A1c, is crucial for patients undergoing coronary artery bypass grafting. Poor glycemic control significantly increases the risk of adverse outcomes, including mortality and infections.
Area of Science:
- Cardiology
- Endocrinology
- Surgical Outcomes
Background:
- Diabetes mellitus is linked to worse outcomes after coronary artery bypass grafting (CABG).
- Hemoglobin A1c (HbA1c) reflects long-term glycemic control.
- The predictive value of HbA1c for adverse events post-CABG is not well-established.
Purpose of the Study:
- To investigate if preoperative hemoglobin A1c levels predict adverse outcomes in patients undergoing CABG.
- To assess the association between glycemic control and in-hospital complications.
Main Methods:
- Retrospective analysis of 3089 patients undergoing elective CABG.
- Preoperative HbA1c levels were prospectively recorded.
- Multivariable logistic regression and ROC curve analysis evaluated HbA1c's association with mortality, renal failure, stroke, myocardial infarction, and wound infection.
Main Results:
- Elevated HbA1c predicted in-hospital mortality (OR 1.40 per unit increase, P=.019).
- HbA1c > 8.6% correlated with a 4-fold increase in mortality.
- Increased HbA1c was associated with higher risks of myocardial infarction, deep sternal wound infection, renal failure, and cerebrovascular accident.
Conclusions:
- Preoperative elevated hemoglobin A1c is a strong predictor of adverse events following CABG.
- HbA1c testing can enhance risk stratification for CABG patients.
- Optimizing glycemic control before CABG may improve patient outcomes.
Objective:
Diabetes mellitus has been associated with an increased risk of adverse outcomes after coronary artery bypass grafting. Hemoglobin A1c is a reliable measure of long-term glucose control. It is unknown whether adequacy of diabetic control, measured by hemoglobin A1c, is a predictor of adverse outcomes after coronary artery bypass grafting.
Methods:
Of 3555 consecutive patients who underwent primary, elective coronary artery bypass grafting at a single academic center from April 1, 2002, to June 30, 2006, 3089 (86.9%) had preoperative hemoglobin A1c levels obtained and entered prospectively into a computerized database. All patients were treated with a perioperative intravenous insulin protocol. A multivariable logistic regression model was used to determine whether hemoglobin A1c, as a continuous variable, was associated with in-hospital mortality, renal failure, cerebrovascular accident, myocardial infarction, and deep sternal wound infection after coronary artery bypass grafting. Receiver operating characteristic curve analysis identified the hemoglobin A1c value that maximally discriminated outcome dichotomies.
Results:
In-hospital mortality for all patients was 1.0% (31/3089). An elevated hemoglobin A1c level predicted in-hospital mortality after coronary artery bypass grafting (odds ratio 1.40 per unit increase, P = .019). Receiver operating characteristic curve analysis revealed that hemoglobin A1c greater than 8.6% was associated with a 4-fold increase in mortality. For each unit increase in hemoglobin A1c, there was a significantly increased risk of myocardial infarction and deep sternal wound infection. By using receiver operating characteristic value thresholds, renal failure (threshold 6.7, odds ratio 2.1), cerebrovascular accident (threshold 7.6, odds ratio 2.24), and deep sternal wound infection (threshold 7.8, odds ratio 5.29) occurred more commonly in patients with elevated hemoglobin A1c.
Conclusion:
Elevated hemoglobin A1c level was strongly associated with adverse events after coronary artery bypass grafting. Preoperative hemoglobin A1c testing may allow for more accurate risk stratification in patients undergoing coronary artery bypass grafting.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Hyperglycemia
Aneurysm IV: Nursing Management
Coronary Artery Disease I: Introduction